CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Enterprise Value: 3.443B for March 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 25, 2024 | 3.443B |
| March 22, 2024 | 3.443B |
| March 21, 2024 | 3.443B |
| March 20, 2024 | 3.442B |
| March 19, 2024 | 3.443B |
| March 18, 2024 | 3.441B |
| March 15, 2024 | 3.440B |
| March 14, 2024 | 3.442B |
| March 13, 2024 | 3.439B |
| March 12, 2024 | 3.439B |
| March 11, 2024 | 3.439B |
| March 08, 2024 | 3.424B |
| March 07, 2024 | 3.422B |
| March 06, 2024 | 3.421B |
| March 05, 2024 | 3.416B |
| March 04, 2024 | 3.409B |
| March 01, 2024 | 3.414B |
| February 29, 2024 | 3.410B |
| February 28, 2024 | 3.419B |
| February 27, 2024 | 3.425B |
| February 26, 2024 | 3.420B |
| February 23, 2024 | 3.414B |
| February 22, 2024 | 3.408B |
| February 21, 2024 | 3.410B |
| February 20, 2024 | 3.411B |
| Date | Value |
|---|---|
| February 16, 2024 | 3.409B |
| February 15, 2024 | 3.411B |
| February 14, 2024 | 3.409B |
| February 13, 2024 | 3.402B |
| February 12, 2024 | 3.412B |
| February 09, 2024 | 2.664B |
| February 08, 2024 | 2.578B |
| February 07, 2024 | 2.468B |
| February 06, 2024 | 2.497B |
| February 05, 2024 | 2.452B |
| February 02, 2024 | 2.448B |
| February 01, 2024 | 2.513B |
| January 31, 2024 | 2.412B |
| January 30, 2024 | 2.408B |
| January 29, 2024 | 2.418B |
| January 26, 2024 | 2.337B |
| January 25, 2024 | 2.272B |
| January 24, 2024 | 2.317B |
| January 23, 2024 | 2.368B |
| January 22, 2024 | 2.447B |
| January 19, 2024 | 2.505B |
| January 18, 2024 | 2.421B |
| January 17, 2024 | 2.449B |
| January 16, 2024 | 2.474B |
| January 12, 2024 | 2.420B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-127.22M
Minimum
Nov 25 2019
3.443B
Maximum
Mar 19 2024
490.96M
Average
206.01M
Median
Enterprise Value Benchmarks
| Gilead Sciences Inc | 76.97B |
| Assure Holdings Corp | 18.00M |
| Societal CDMO Inc (DELISTED) | 145.26M |
| AN2 Therapeutics Inc | -36.00M |
| Madrigal Pharmaceuticals Inc | 3.661B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.90M |
| Revenue (Quarterly) | 0.057M |
| Total Expenses (Quarterly) | 42.56M |
| EPS Diluted (Quarterly) | -0.37 |
| Profit Margin (Quarterly) | -73.51K% |
| Earnings Yield | -3.05% |
| Normalized Earnings Yield | -3.048 |